JUN 13, 2019 11:44 AM PDT

Proton Therapy May Reduce Second Cancer Risk More Than Other Radiation Types

WRITTEN BY: Julia Travers

A new study finds that proton beam radiation therapy (PBRT) might lead to a reduction in the risk for a second cancer, when compared to other types of contemporary radiation therapy. The researchers analyzed National Cancer Database (NCDB) data on adult and pediatric patients with cancer. It used the data to determine the second-cancer risk associated with three types of radiation therapy (RT):  PBRT, intensity-modulated radiation therapy (IMRT) and three-dimensional conformal radiation therapy (3DCRT). The therapies included were administered between 2004 and 2016 to patients of diverse ages, and those with metastatic disease were not included.

PBRT, credit: public domain

PBRT Study Design and Findings

Head and/or neck, breast, gastrointestinal, gynecologic, non–small cell lung, prostate, bone/soft tissue, lymphoma and brain/central nervous system tumors were included. The total number of patients whose data were analyzed was 450,373. The percentage of people who also received chemotherapy was higher in the 3DCRT group, at 48 percent, and lower in the IMRT and PBRT groups, which were at 38 and 17 percent, respectively. PBRT was used most with prostate tumors. Head and neck cancers were treated primarily with IMRT, and 3DCRT was utilized most often for breast cancers.

The crude absolute incidence rate of subsequent cancer diagnosis per 100 patient-years was 1.60 in the 3DCRT cohort, 1.55 in the IMRT cohort, and 0.44 in the PBRT cohort.

PBRT Study Conclusions and Limitations

“Patients most likely to benefit from PBRT may be [children] and young adults due to the potential for a long life expectancy and increased susceptibility to treatment-related malignancies,” Michael Xiang, M.D., Ph.D., of Stanford University, said.

Some of the study’s constraints were tied to the NCDB, which does not allow researchers to discern the location of a second cancer relative to an RT field. The database also does not account for risk factors like obesity or smoking, among other limitations.

To learn the basics of how proton therapy treats cancer, check out the video below.

Source: ASCO News

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
SEP 15, 2020
Cancer
Soy helps post-op treatment of bone cancer
SEP 15, 2020
Soy helps post-op treatment of bone cancer
New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 30, 2020
Cancer
Fighting mesothelioma with curcumin
OCT 30, 2020
Fighting mesothelioma with curcumin
Research led by investigators at Flinders University in Australia is spearheading new developments in cancer prevention ...
NOV 03, 2020
Genetics & Genomics
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
NOV 03, 2020
One Eight Cancer Patients Also Carry Inherited Genetic Mutations
Genetic sequencing technologies have rapidly advanced, reducing the time required to sequence the entire human genome fr ...
NOV 09, 2020
Cancer
A Prognostic Expression Profile for Osteosarcoma
NOV 09, 2020
A Prognostic Expression Profile for Osteosarcoma
Tireless research goes into every cancer diagnostic tools and new therapy. Many types of cancer have made giant steps fo ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
Loading Comments...